Navigation Links
BYDUREON™ RECEIVES MARKETING AUTHORIZATION IN EUROPE
Date:6/21/2011

digesting food. Antibodies may develop with use of BYETTA. Patients who develop high titers to exenatide could have worsening or failure to achieve adequate glycemic control. Consider alternative therapy if this occurs. Severe allergic reactions can happen with BYETTA. There have been no clinical studies establishing conclusive evidence of macrovascular risk reduction with BYETTA or any other antidiabetic drug.

The most common side effects with BYETTA include nausea, vomiting, diarrhea, dizziness, headache, feeling jittery, and acid stomach. Nausea most commonly happens when first starting BYETTA, but may become less over time.

These are not all the side effects from use of BYETTA. A healthcare provider should be consulted about any side effect that is bothersome or does not go away.

For additional important safety information about BYETTA, please see the full Prescribing Information (www.byetta.com/pi) and Medication Guide (www.byetta.com/mg).

About Amylin, Lilly and Alkermes

Amylin and Lilly partnered to develop and market BYDUREON, which is based on proprietary technology for long-acting medications developed by Alkermes, Inc. BYDUREON was approved in the EU in June 2011 and is under regulatory review in the U.S.

Amylin Pharmaceuticals is a biopharmaceutical company dedicated to improving lives of patients through the discovery, development and commercialization of innovative medicines. Amylin's research and development activities leverage the Company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is headquartered in San Diego.

Through a long-standing commitment to diabetes care, Lilly provides patients with breakthrough treatments that enable them to live longer, healthier and fuller lives. Since 1923, Lilly has b
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. BYDUREON™ Recommended for Approval in Europe
2. Amylin, Lilly and Alkermes Announce Receipt of Complete Response Letter from FDA for BYDUREON™
3. BYETTA® and BYDUREON™ to be Featured in More Than a Dozen Study Presentations at EASD 2010
4. Access Pharmaceuticals Receives Letter of Acceptance For MuGard Filing From SFDA of China
5. Omnicells OmniRx Automated Medication Dispensing System Receives 2011 Best in KLAS Award
6. EndoSphere Inc. Receives Patent for Obesity Treatment
7. Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease
8. TrueBeam™ System for Non-Invasive Image-Guided Cancer Treatment Receives Shonin Approval
9. Ventana Medical Systems, Inc. Receives FDA Approval for the First Fully Automated Diagnostic Assay for HER2 Gene Status Determination in Breast Cancer Patients
10. Mindray Medical Receives the 2011 Medical Device Excellence Award for its V Series Patient Monitoring System
11. MGT Capital Investments Receives NYSE Amex Listing Deficiency Notification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 21, 2014 The spinal column is one of ... Signals carried to and from the brain through the column ... system. Injury or ailment here can be life altering, and ... of control over their body. Though back injury and disease ... there are more options available to make things better than ...
(Date:8/21/2014)... , Aug. 21, 2014  Decision Resources ...  physicians in Brazil and ... clinical guidelines and commonly prescribe long-acting beta-agonist (LABA)- ... they do so within current severe cost/coverage constraints. ... that are expected to launch in these countries—which ...
(Date:8/21/2014)... , Aug. 21, 2014  Seventy-one percent of Americans believe ... is a serious public health and safety issue in ... a survey released today by Repass & Partners, a ... "Americans understand the severity of the prescription medication abuse ... with this very serious health situation facing our country," ...
Breaking Medicine Technology:Don't Live in Pain: Four Life Improving Benefits of Back Surgery 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 3Consumers Desperate For Measures To Curb Prescription Drug Abuse 2Consumers Desperate For Measures To Curb Prescription Drug Abuse 3
... Reportlinker.com announces that a new market research ... Insulin Patch Pumps ... inhaled insulin market in 2008 has resulted in ... now appears that the patch pump – a ...
... Reportlinker.com announces that a new market ... The Outlook for Pharmaceuticals ... http://www.reportlinker.com/p0203102/The-Outlook-for-Pharmaceuticals-in-Central-Asia.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=NoCategory These reports provide ... most populous countries in the world and ...
Cached Medicine Technology:Insulin Patch Pumps 2The Outlook for Pharmaceuticals in Central Asia 2The Outlook for Pharmaceuticals in Central Asia 3The Outlook for Pharmaceuticals in Central Asia 4
(Date:8/23/2014)... (PRWEB) August 23, 2014 GranuFlo ... 2012 GranuFlo and NaturaLyte dialysis concentrate recall continue ... in U.S. District Court, District of Massachusetts, Bernstein ... report issued by the U.S. Judicial Panel on ... 2,028 claims are pending in the proceeding. In ...
(Date:8/23/2014)... 2014 According to the new ... Application and Geography - Regional Trends & Forecast ... Market with an analysis and forecast of value ... of electronic adhesives by applications and geography are ... market data tables and 26 figures spread through ...
(Date:8/23/2014)... PA (PRWEB) August 23, 2014 "When ... sometimes comes into contact with the dirty water inside ... the seat itself," said one of two inventors from ... to germs, we developed this protective device." , They ... unsanitary toilet surfaces, including the water, bowl and seat. ...
(Date:8/23/2014)... 2014 Hundreds of Wright hip ... of individuals who were allegedly harmed by devices ... to move forward in the U.S. District Court, ... According to an Order dated August 19th, the ... would allow the litigation’s first case to go ...
(Date:8/23/2014)... York, NY (PRWEB) August 23, 2014 ... (NYT) reported on a data breach suffered by ... that saw the compromise of 4.5 million records containing ... social security numbers. According to Mandiant, who was engaged ... emanated from an advanced group of cyber attackers ...
Breaking Medicine News(10 mins):Health News:GranuFlo Lawsuits Mount in Federal Litigation, as Filings Surpass 2,000, Bernstein Liebhard LLP Reports 2Health News:GranuFlo Lawsuits Mount in Federal Litigation, as Filings Surpass 2,000, Bernstein Liebhard LLP Reports 3Health News:GranuFlo Lawsuits Mount in Federal Litigation, as Filings Surpass 2,000, Bernstein Liebhard LLP Reports 4Health News:Electronic Adhesives Market Poised to Reach $5.5 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Electronic Adhesives Market Poised to Reach $5.5 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Wright Conserve Hip Lawsuits Move Forward, as Federal Court Issues Order Pertaining to Bellwether Trials, Bernstein Liebhard LLP Reports 2Health News:Wright Conserve Hip Lawsuits Move Forward, as Federal Court Issues Order Pertaining to Bellwether Trials, Bernstein Liebhard LLP Reports 3Health News:Wright Conserve Hip Lawsuits Move Forward, as Federal Court Issues Order Pertaining to Bellwether Trials, Bernstein Liebhard LLP Reports 4Health News:This Time Prominent Hospital Group Falls Prey to Hackers Believed to be Based in China 2Health News:This Time Prominent Hospital Group Falls Prey to Hackers Believed to be Based in China 3Health News:This Time Prominent Hospital Group Falls Prey to Hackers Believed to be Based in China 4
... cells to spread from a primary site, to form ... process in which cell motility and invasion play a ... develops is identification of the molecules, and characterisation of ... mechanisms have been poorly understood. Now, a team of ...
... with diabetes have the weight-loss surgery? , , SUNDAY, Dec. ... bypass surgery extends the lives of obese patients is ... go under the knife and who shouldn,t. , ... patients who traditionally haven,t been candidates for the weight-loss ...
... breast cancer prevention study using exemestane (Aromasin) finds an ... II study details reported today, by Jennifer Eng-Wong, MD, ... Center at the San Antonio Breast Cancer Symposium, examines ... at an increased risk of developing breast cancer based ...
... transcript of President Bush,s weekly radio address to the nation: , ... week, our country received good news in the fight against illegal drugs. ... to decline -- and that we are making good progress in our ... , , Substance abuse is a serious ...
... leading healthcare provider of interim and executive placement and consulting solutions, ... board and CEO services. Formerly vice president, senior executive search, Noland ... for hospitals, home care companies, health systems and national healthcare organizations. ... ...
... retail locations joining national partners in effort to raise $5 ... Dec. 12 National partners from the 17th annual ... Memphis today to celebrate raising more than $2.4 million to ... , , Companies represented at ...
Cached Medicine News:Health News:Gastric Bypass Success Sparks Debate 2Health News:Gastric Bypass Success Sparks Debate 3Health News:Radio Address by President Bush to the Nation 2Health News:Radio Address by President Bush to the Nation 3Health News:Noland Named Vice President, Board & CEO Services for B. E. Smith 2Health News:More Than $2.4 Million Raised by National Halloween Promotion Partners to Help St. Jude Fight Childhood Cancer 2
Platelet agitator....
I-125 competitive RIA kit for the detection of Progesterone....
... quantitative determination of progesterone ... Progesterone EIA is ... of competitive binding between ... specimen and progesterone-HRP conjugate ...
ELISA for the detection of Insulin....
Medicine Products: